Jump to content

Johnson & Johnson begins Phase III clinical trial for a COVID-19 vaccine


Recommended Posts

Posted

The American company has begun the massive final stage of clinical trials for its single-dose COVID-19 vaccine. If the trial shows the vaccine is safe and effective, Johnson & Johnson anticipates the first batches of the vaccine will be available "for emergency use authorization in early 2021."

EinET-DXcAIM8SX?format=jpg&name=medium

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...